ABL Diagnostics (XPAR:ABLD) Dividends per Share : €0.00 (TTM As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Dividends per Share?

ABL Diagnostics's dividends per share for the six months ended in Jun. 2023 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, ABL Diagnostics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

ABL Diagnostics Dividends per Share Historical Data

The historical data trend for ABL Diagnostics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Dividends per Share Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividends per Share

Get a 7-Day Free Trial

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ABL Diagnostics's Dividends per Share

For the Health Information Services subindustry, ABL Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABL Diagnostics's Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Dividend Yield % falls into.

ABL Diagnostics Dividends per Share Calculation

Dividends paid to per common share.

ABL Diagnostics (XPAR:ABLD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

ABL Diagnostics's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	-0.029
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

ABL Diagnostics Dividends per Share Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines